Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The potential of LINGO-1 as a therapeutic target for essential tremor.
[Phenotypes of Charcot-Marie-Tooth Syndrome and Differential Diagnosis Focused in Inflammatory Neuropathies].
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Chronic inflammatory demyelinating polyneuropathy with papillodema and response to immunoglobulins.
Positive association of vitamin d receptor gene variations with multiple sclerosis in South East Iranian population.
Dendritic cells as therapeutic targets in neuroinflammation.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Myelinating and demyelinating phenotype of Trembler-J mouse (a model of Charcot-Marie-Tooth human disease) analyzed by atomic force microscopy and confocal microscopy.
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
[Chronic inflammatory demyelinating polyradiculoneuropathy(CIDP): Treatment and prognosis].
Clinical perspectives of TRAIL: insights into central nervous system disorders.
Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.
Galactorrhea in a Patient With Aquaporin-4 Antibody-positive Neuromyelitis Optica Spectrum Disorder: A Case Report and Review of the Literature.
Demyelinating diseases in Asia.
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
A systematic review of stress-management interventions for multiple sclerosis patients.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Pain in acquired inflammatory demyelinating polyneuropathies.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Highly polarized Th17 cells induce EAE via a T-bet-independent mechanism.
Cellulose/soy protein composite-based nerve guidance conduits with designed microstructure for peripheral nerve regeneration.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
T-cell responses to distinct AQP4 peptides in patients with neuromyelitis optica (NMO).
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
Pages
« first
‹ previous
…
673
674
675
676
677
678
679
680
681
…
next ›
last »